Keywords: fda, panel, backs, sertindole, safety, issues, raised

FDA Panel Backs Sertindole, But Safety Issues Raised

Article | 22 July 1996

Print This

Shortly after the first launch of the drug in the UK by originator Lundbeck, the antipsychotic sertindole has been recommended ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in